Shamaa et al. in Egypt noted a frequency of 34.6 and 28.8% in FLT3-ITD and NPM1 mutations respectively in a cohort of AML patients with a normal karyotype, like western studies. This evidence concerns the gene NPM1 and acute myeloid leukemia.